Pietro Geri

790 total citations · 1 hit paper
27 papers, 408 citations indexed

About

Pietro Geri is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Pietro Geri has authored 27 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Pietro Geri's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Systemic Sclerosis and Related Diseases (7 papers) and Respiratory and Cough-Related Research (5 papers). Pietro Geri is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Systemic Sclerosis and Related Diseases (7 papers) and Respiratory and Cough-Related Research (5 papers). Pietro Geri collaborates with scholars based in Italy, United Kingdom and United States. Pietro Geri's co-authors include Marco Confalonieri, Francesco Salton, Barbara Ruaro, Paola Confalonieri, Elisa Baratella, Riccardo Pozzan, Giovanni Fontana, Massimo Pistolesi, Federico Lavorini and Michael Hughes and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Frontiers in Immunology and Frontiers in Physiology.

In The Last Decade

Pietro Geri

27 papers receiving 399 citations

Hit Papers

Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights ... 2024 2026 2025 2024 10 20 30

Peers

Pietro Geri
Pietro Geri
Citations per year, relative to Pietro Geri Pietro Geri (= 1×) peers Ömer Özbudak

Countries citing papers authored by Pietro Geri

Since Specialization
Citations

This map shows the geographic impact of Pietro Geri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pietro Geri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pietro Geri more than expected).

Fields of papers citing papers by Pietro Geri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pietro Geri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pietro Geri. The network helps show where Pietro Geri may publish in the future.

Co-authorship network of co-authors of Pietro Geri

This figure shows the co-authorship network connecting the top 25 collaborators of Pietro Geri. A scholar is included among the top collaborators of Pietro Geri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pietro Geri. Pietro Geri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castaldo, Nadia, Vincenzo Patruno, Michael Hughes, et al.. (2025). Retrospective Observational Study of Nintedanib in Managing Idiopathic and Progressive Pulmonary Fibrosis in Routine Practice. Journal of Clinical Medicine. 14(18). 6665–6665. 1 indexed citations
2.
Salton, Francesco, Paola Confalonieri, Pietro Geri, et al.. (2025). Comorbidities’ Effect on IPF: Pathogenesis and Management. Biomedicines. 13(6). 1362–1362. 1 indexed citations
3.
Salton, Francesco, Paola Confalonieri, Pietro Geri, et al.. (2025). Assessment of Treatment Effects of Aminaphtone by Capillaroscopy in a Patient with Raynaud’s Phenomenon. Pharmaceuticals. 18(2). 203–203. 1 indexed citations
4.
Confalonieri, Paola, Francesco Salton, Metka Kodric, et al.. (2024). Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease. Pharmaceuticals. 17(9). 1147–1147. 4 indexed citations
5.
Salton, Francesco, Paola Confalonieri, Pietro Geri, et al.. (2024). Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant. Pharmaceuticals. 17(7). 930–930. 4 indexed citations
6.
Salton, Francesco, Paola Confalonieri, Pietro Geri, et al.. (2024). Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows. Pharmaceuticals. 17(6). 709–709. 37 indexed citations breakdown →
7.
Maggio, Giuseppe, Paola Confalonieri, Francesco Salton, et al.. (2023). Biomarkers in Systemic Sclerosis: An Overview. Current Issues in Molecular Biology. 45(10). 7775–7802. 13 indexed citations
8.
Ruaro, Barbara, Paola Confalonieri, Riccardo Pozzan, et al.. (2023). Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story?. Heliyon. 9(4). e14768–e14768. 4 indexed citations
9.
Ruaro, Barbara, Paola Confalonieri, Riccardo Pozzan, et al.. (2022). Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?. Journal of Clinical Medicine. 11(13). 3577–3577. 13 indexed citations
10.
Ruaro, Barbara, Elisa Baratella, Paola Confalonieri, et al.. (2022). Chronic Thromboembolic Pulmonary Hypertension: An Update. Diagnostics. 12(2). 235–235. 32 indexed citations
11.
Ruaro, Barbara, Francesco Salton, Elisa Baratella, et al.. (2022). An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients. Diagnostics. 12(3). 616–616. 21 indexed citations
12.
Ruaro, Barbara, Riccardo Pozzan, Paola Confalonieri, et al.. (2022). Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?. Pharmaceuticals. 15(8). 1033–1033. 40 indexed citations
13.
Ruaro, Barbara, Paola Confalonieri, Elisa Baratella, et al.. (2022). Chronic Thromboembolic Pulmonary Hypertension: An Observational Study. Medicina. 58(8). 1094–1094. 12 indexed citations
14.
Ruaro, Barbara, Elisa Baratella, Paola Confalonieri, et al.. (2021). High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose?. Diagnostics. 11(12). 2293–2293. 13 indexed citations
15.
Ruaro, Barbara, Elisa Baratella, Paola Confalonieri, et al.. (2021). High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients. Diagnostics. 11(11). 1960–1960. 34 indexed citations
16.
Ruaro, Barbara, Marco Confalonieri, Francesco Salton, et al.. (2021). The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients. Pharmaceuticals. 14(5). 403–403. 19 indexed citations
17.
Ruaro, Barbara, Cosimo Bruni, Barbara Wade, et al.. (2021). Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage?. Frontiers in Physiology. 12. 710298–710298. 12 indexed citations
18.
Albani, Stefano, Bruno Pinamonti, Enrico Fabris, et al.. (2020). Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders. International journal of cardiac imaging. 36(7). 1213–1225. 14 indexed citations
19.
Lavorini, Federico, Giovanni Fontana, Tito Pantaleo, et al.. (2007). Fog-induced Cough with Impaired Respiratory Sensation in Congenital Central Hypoventilation Syndrome. American Journal of Respiratory and Critical Care Medicine. 176(8). 825–832. 20 indexed citations
20.
Lavorini, Federico, et al.. (2006). Speed of onset of bronchodilator response to salbutamol inhaled via different devices in asthmatics: a bioassay based on functional antagonism. British Journal of Clinical Pharmacology. 62(4). 403–411. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026